Imatinib Mesylate, Interferon Alfa, and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

This study is currently recruiting participants.

Study NCT00363649 Information provided by National Cancer Institute (NCI)

First Received: August 10, 2006 Last Updated: July 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)